Literature DB >> 12663442

Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.

Tamotsu Ichiba1, Takanori Teshima, Rork Kuick, David E Misek, Chen Liu, Yuichiro Takada, Yoshinobu Maeda, Pavan Reddy, Debra L Williams, Samir M Hanash, James L M Ferrara.   

Abstract

The liver, skin, and gastrointestinal tract are major target organs of acute graft-versus-host disease (GVHD), the major complication of allogeneic bone marrow transplantation (BMT). In order to gain a better understanding of acute GVHD in the liver, we compared the gene expression profiles of livers after experimental allogeneic and syngeneic BMT using oligonucleotide microarray. At 35 days after allogeneic BMT when hepatic GVHD was histologically evident, genes related to cellular effectors and acute-phase proteins were up-regulated, whereas genes largely related to metabolism and endocrine function were down-regulated. At day 7 after BMT before the development of histologic changes in the liver, interferon gamma (IFN-gamma)-inducible genes, major histocompatibility (MHC) class II molecules, and genes related to leukocyte trafficking had been up-regulated. Immunohistochemistry demonstrated that expression of IFN-gamma protein itself was increased in the spleen but not in hepatic tissue. These results suggest that the increased expression of genes associated with the attraction and activation of donor T cells induced by IFN-gamma early after BMT is important in the initiation of hepatic GVHD in this model and provide new potential molecular targets for early detection and intervention of acute GVHD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663442     DOI: 10.1182/blood-2002-09-2748

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease.

Authors:  Mi Jeong Kim; Roberto Romero; Chong Jai Kim; Adi L Tarca; Sovantha Chhauy; Christopher LaJeunesse; Deug-Chan Lee; Sorin Draghici; Francesca Gotsch; Juan Pedro Kusanovic; Sonia S Hassan; Jung-Sun Kim
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

Review 2.  Acute phase response in animals: a review.

Authors:  Carolyn Cray; Julia Zaias; Norman H Altman
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

3.  Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease.

Authors:  Sydney X Lu; Amanda M Holland; Il-Kang Na; Theis H Terwey; Onder Alpdogan; Jhoanne L Bautista; Odette M Smith; David Suh; Christopher King; Adam Kochman; Vanessa M Hubbard; Uttam K Rao; Nury Yim; Chen Liu; Alvaro C Laga; George Murphy; Robert R Jenq; Johannes L Zakrzewski; Olaf Penack; Lindsay Dykstra; Kevin Bampoe; Lia Perez; Bruce Furie; Barbara Furie; Marcel R M van den Brink
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

4.  Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels.

Authors:  Chien-Chun Steven Pai; Hui-Hua Hsiao; Kai Sun; Mingyi Chen; Takeshi Hagino; Joseph Tellez; Christine Mall; Bruce R Blazar; Arta Monjazeb; Mehrdad Abedi; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2014-07-23       Impact factor: 5.742

5.  Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.

Authors:  Christian A Wysocki; Qi Jiang; Angela Panoskaltsis-Mortari; Patricia A Taylor; Karen P McKinnon; Lishan Su; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

Review 6.  Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance.

Authors:  Chong Jai Kim; Roberto Romero; Piya Chaemsaithong; Jung-Sun Kim
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

7.  Sequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): early role for STAT1 and STAT3.

Authors:  Hui-Hui Ma; Judy Ziegler; Cuiling Li; Antonia Sepulveda; Ahmed Bedeir; Jennifer Grandis; Suzanne Lentzsch; Markus Y Mapara
Journal:  Cell Immunol       Date:  2011-02-04       Impact factor: 4.868

8.  Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin.

Authors:  J S Lehman; S Dasari; S S Damodaran; R A El-Azhary; L E Gibson; S K Hashmi; W J Hogan; S J Kenderian; M S Patnaik; M R Litzow; H M Lazarus; A Meves
Journal:  Clin Exp Dermatol       Date:  2018-10-02       Impact factor: 3.470

9.  Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.

Authors:  Pavan Reddy; Yoshinobu Maeda; Kevin Hotary; Chen Liu; Leonid L Reznikov; Charles A Dinarello; James L M Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

10.  Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease.

Authors:  Yong Zhu Jin; Brian D Thompson; Zho Yan Zhou; Yineng Fu; Lutz Birnbaumer; Mei X Wu
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.